Clorox (CLX) Liabilities and Shareholders Equity (2009 - 2026)

Clorox has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $7.8 billion in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 40.15% year-over-year to $7.8 billion in Q2 2026; TTM through Jun 2026 was $25.4 billion, a 14.56% increase from a year earlier, with the FY2026 full-year figure at $7.8 billion, up 40.15% from the prior year.
• Liabilities and Shareholders Equity was $7.8 billion for Q2 2026 at Clorox, up from $6.4 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $7.8 billion in Q2 2026, with the low at $5.5 billion in Q3 2024.
• Average Liabilities and Shareholders Equity over 5 years is $6.0 billion, with a median of $5.9 billion recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity fell 8.25% in 2024, then surged 40.15% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $6.0 billion in 2022, then dropped by 2.27% to $5.9 billion in 2023, then fell by 5.6% to $5.6 billion in 2024, then grew by 0.65% to $5.6 billion in 2025, then jumped by 38.86% to $7.8 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $7.8 billion (Q2 2026), $6.4 billion (Q1 2026), and $5.6 billion (Q4 2025), per Business Quant data.